Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Poop pills could help kids with colitis stay healthy

NCT ID NCT05202990

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether frozen stool capsules (fecal transplants) can help children aged 8-17 with ulcerative colitis stay in remission after steroid treatment. Participants will receive either capsules or enemas containing healthy donor stool. The main goal is to see if the capsules increase gut bacteria diversity at 6 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Fecal microbiota transplantation (FMT) via frozen stool capsules
What this could lead to
If successful, this could offer a less invasive way to maintain remission in children with ulcerative colitis by restoring healthy gut bacteria.
What could go wrong
This is a small early-phase trial with only 26 participants, so results may not apply broadly. The treatment involves colonoscopy and swallowing many capsules, which some children may find difficult.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 26 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 17 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for patients: * Patient aged 8 to 17 years old * Ulcerative colitis (UC), whatever the extent, except isolated proctitis (\<5 cm), diagnosed for more than 3 months according to the usual clinical, biological and endoscopic criteria * Moderate active UC defined by a PUCAI score \> 35 and responding to corticosteroid treatment with a PUCAI score \<10 at enrollment * Treatment of UC (5-ASA, immunosuppressants, biotherapies) stable for more than 3 months * Patient able to swallow test capsules * For girls of childbearing age: * To have a negative blood (or urine) pregnancy test * To agree to use a reliable contraceptive method from visit 1 until the end of the research * Patient with health insurance * Informed written consent form signed by both parents or by the person (s) with parental authority Exclusion Criteria for patients: * isolated proctitis (\<5 cm) * Being on enteral nutrition * Have received antibiotic or antifungal treatment in the 4 weeks prior to enrollment * Having a Clostridioides difficile infection in the 4 weeks prior to enrollment; * Being pregnant or breastfeeding, or have a positive pregnancy test; * Have a contraindication to colonoscopy or general anaesthesia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pediatric ulcerative colitis in remission are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Pediatric Gastroenterology, Hepatology and Nutrition - Necker - Enfants Malades Hospital

    Paris, 75015, France

  • Department of Pediatric Gastroenterology, Robert Debré Hospital

    Paris, 75019, France

  • Department of gastroenterology, Armand Trousseau Hospital

    Paris, 75012, France